I Ks channels open in response to depolarization of the membrane voltage during the cardiac action potential, passing potassium ions outward to repolarize ventricular myocytes and end each beat. Here, we show that the voltage required to activate I Ks channels depends on their covalent modification by small ubiquitin-like modifier (SUMO) proteins. I Ks channels are comprised of four KCNQ1 poreforming subunits, two KCNE1 accessory subunits, and up to four SUMOs, one on Lys 424 of each KCNQ1 subunit. Each SUMO shifts the half-maximal activation voltage (V 1/2 ) of I Ks ∼ +8 mV, producing a maximal +34-mV shift in neonatal mouse cardiac myocytes or Chinese hamster ovary (CHO) cells expressing the mouse or human subunits. Unexpectedly, channels formed without KCNE1 carry at most two SUMOs despite having four available KCNQ1-Lys 424 sites. SUMOylation of KCNQ1 is KCNE1 dependent and determines the native attributes of cardiac I Ks in vivo. KCNE1 | minK | KCNQ1 | KvLQT1 | heart C ardiac I Ks channels pass the slow component of the delayed rectifier potassium current that is necessary to produce normal heart rate and rhythm. Thus, I Ks varies in magnitude and timing subject to neuronal and hormonal influences (1) . Abnormal changes in I Ks function, due to inherited mutations in KCNQ1 or KCNE1, or suppression of the current by medications, can produce long QT syndrome (LQTS) and life-threatening cardiac arrhythmias (2) . KCNQ1 (also called K V 7.1 and previously K V LQT) is a classical voltage-gated potassium α-subunit with six transmembrane segments and a single pore-forming P loop. Human KCNQ1 has variants up to 676 residues in length, whereas KCNE1 (minK) has just 129 residues and a single transmembrane span (Fig. 1A) . Despite its small size, KCNE1 is essential to the operation of I Ks . Compared with channels formed by KCNQ1 subunits alone, KCNE1 produces a right shift in the half-maximal voltage required to activate the channel (V 1/2 ), slows the kinetics of activation and deactivation, increases the channel unitary conductance, alters the ion selectivity of the conduction pore and, modifies its pharmacology (3) (4) (5) (6) (7) (8) . KCNE1 also endows I Ks channel with a high affinity for PIP 2 (9) and allows responsiveness to PKA-mediated phosphorylation following β-adrenergic stimulation (10) . Here, we demonstrate that the V 1/2 inherent to native cardiac I Ks channels results from, and is modified by, KCNE1-dependent SUMOylation of KCNQ1.
SUMOylation is the enzyme-mediated linkage of one of three SUMO isoforms to the e-amino group of specific Lys residues on a target protein (11) . Present in all eukaryotic cells, the pathway was recognized to regulate the activity of nuclear transcription factors when we discovered it resident at the plasma membrane (12, 13) and to regulate the excitability of cerebellar granule neurons via SUMOylation of K2P1 and Na V 1.2 (14, 15) , and of hippocampal neurons via modification of K V 2.1 (16) .
This study was inspired by the work of Qi et al. (17) , who describe partial deficiency of the deSUMOylating enzyme SENP2 in mice, showing it to produce seizures, bradycardia, and sudden death, in association with decreased M-channel currents and increased modification of KCNQ2 (K V 7.2) subunits by SUMO2 in the brain. Supporting a neurogenic basis for sudden cardiac death, the authors report sinus pauses and AV conduction block following seizure activity; because they also observe increased SUMOylation of KCNQ1 in the brain by SUMO2, and others have shown that mice carrying human LQTS mutations in KCNQ1 can develop seizures and sudden death (18) , we chose to study the effects of SUMOylation of KCNQ1 in the heart on the operation of I Ks .
To overcome the paucity of I Ks in adult mouse heart, we used a strategy for electrophysiology developed by others that allows study of the current in neonatal cardiac ventricular myocytes (nCM) (19) (20) (21) (22) . In nCM, we first used partial SENP2 knockdown and observed that the conductance-voltage relationship of native cardiac I Ks was subject to tonic regulation by the SUMO pathway; the response was then characterized directly by the acute intracellular application of SUMO2 and SENP2. Reconstituting the channels in CHO cells with mouse or human KCNQ1 and KCNE1 subunits allowed identification of a single conserved SUMOylated residue-Lys 424 in human KCNQ1-that determined the basis for voltage dependence of I Ks channels. Total internal reflection fluorescent (TIRF) microscopy allowed counting of the number of KCNE1, KCNQ1, and SUMO2 subunits in channel complexes, and with electrophysiology, the effect of adding 1, 2, 3, and 4 SUMO2 monomers on the V 1/2 of I Ks activation was shown to be linearly additive. Compared with channels formed with only KCNQ1 subunits, KCNE1 incorporation to create I Ks channels shifts the V 1/2 by +38 mV; SUMOylation of all four sites in I Ks channels yields an additional shift of +34 mV. SUMOylation was not associated with changes in the surface density or the subunit stoichiometry of I Ks channels.
Significance
The slow delayed rectifier K + current (I Ks ) determines the length of each human heartbeat because it activates after myocytes are excited and depolarize. This sensitivity to voltage, as well as dynamic regulation by hormones and second messengers, underlies the essential role of I Ks in determining the duration and rhythm of cardiac action potentials. Here, we demonstrate the unexpected mechanism that establishes the voltage-dependent operation of I Ks channels: SUMOylation. When native I Ks channels are resident in the plasma membranes of neonatal mouse ventricular myocytes, or human channels are reconstituted in CHO cells, each of the four KCNQ1 pore-forming subunits is subject to monoSUMOylation in a manner that depends on KCNE1 accessory subunits, leading to stepwise depolarizing shifts in the activation voltage.
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Results

SUMO2 and SENP2 Regulate I Ks in Neonatal Mouse Cardiac Ventricular
Myocytes. Whole-cell patch-clamp recording was used to study I Ks 72 h after dissociation of nCM from the harvested heart. The recording protocol was designed to isolate the slow component of the delayed rectifier potassium current, as reported by others (19) (20) (21) (22) (23) . Briefly, a holding potential of −40 mV was used to inactivate the voltage-gated Na + channels and 1 μM isradipine was included in the bath solution to block voltage-gated calcium channel currents. Native I Ks was defined per custom as the difference current isolated by subtraction of the current measured in the presence of 30 μM Chromanol-293B, a I Ks inhibitor, from the current measured before application of the drug (23) (24) (25) (26) . All currents were evoked by test pulses lasting 2 s from −60 to +60 mV in 20-mV increments, followed by 2-s tail current pulses to −40 mV and interpulse intervals of 15 s. The tail currents were used to assess isochronal conductance-voltage relationships (iG-V) and current densities, the latter after a step to +40 mV; biophysical parameters for nCM are summarized in Table 1 .
Native I Ks in nCM was similar in appearance to the macroscopic, Chromanol-293B-sensitive, time-dependent, slowly activating delayed rectifier currents reported by others, including an apparent V 1/2 of ∼+10 mV ( Fig. 1B) (19, 20, (27) (28) (29) . nCM expressing a scrambled shRNA and eGFP expressed from a lentivirus retained parameters for I Ks like those in wild-type cells. In contrast, nCM expressing eGFP and shRNA directed to SENP2 showed a 51 ± 6% decrease in SENP2 mRNA by qPCR and a right shift in V 1/2 to 28 ± 2 mV, decreased current density, slowed activation rates, and faster deactivation kinetics ( Fig. 1 C and D and Table 1 ). These findings led us to hypothesize that partial knockdown of the SENP2 mRNA level could regulate the voltage-dependent activation of native I Ks . To confirm the hypothesis that the right shift in the V 1/2 was due to suppression of deSUMOylase activity and increased SUMOylation, we introduced 1 nM SUMO2 into the cells via the recording pipette, a manipulation that we have previously shown to produce maximal SUMOylation of potassium channels in central neurons or expressed heterologously in CHO cells (13, 16) . Currents evoked in the presence of 1 nM SUMO2 had a V 1/2 of 26 ± 2 mV, and manifested current densities and gating kinetics similar in magnitude to those observed in cells treated with SENP2 shRNA. In contrast, addition of 1 nM SENP2 in the pipette left-shifted the V 1/2 to −3.3 ± 1.4 mV, increased the current density, speeded the kinetics of activation, and slowed the time course for deactivation. Of note, the Chromanol-293B-insensitive potassium currents in the nCM (i.e., the non-I Ks currents) appeared to be unaltered by treatment with SENP2 shRNA or scrambled shRNA, or by the inclusion of SUMO2 or SENP2 in the pipette (Fig. S1 ). Based on our experience with other ion channels, we suspected that SUMO2 regulation of I Ks would result from direct modification of the channel. To test this notion, we reconstituted the channel by expression of human clone KCNQ1 and KCNE1 subunits in CHO cells and observed that the regulatory behaviors seen in the nCM were recapitulated (Fig. 2 ). In accord with expectations from our prior studies of I Ks in CHO cells (30) , I Ks channels with human subunits had a V 1/2 of 25 ± 1.0 mV under Fig. 1 . SUMO regulates I Ks in neonatal mouse cardiac ventricular myocytes. nCM were identified by visualization of muscular striations and spontaneous beating. I Ks was isolated with 30 μM Chromanol-293B in the bath by the protocols described in the main text and Materials and Methods; biophysical parameters are in Table 1 as mean ± SEM for n = 6-11 cells. Currents measured before application of Chromanol-293B and the Chromanol-293B-insensitive current are shown in Fig. 1 . V 1/2 and Zδ were determined from a Boltzmann function using tail current densities at −40 mV. The tail current density was assessed by estimating the peak from a fit of the decay curve after an activating pulse at +40 mV for 2 s. The τ for activation and deactivation was determined from a single exponential fit in each experimental condition. Data are mean ± SEM with 6-11 cells. Lentivirus treated cells were studied 48 h following infection. Currents measured before application of 30 μM Chromanol-293B, and the Chromanol-293-insensitive current are show in Fig. S1 . Compared with the control condition, V 1/2 , current density, and τ for activation and deactivation were significantly different with SENP2 or SUMO2 in the pipette, and when cells were treated with shRNA SENP2 (unpaired t test, *P < 0.01), whereas there was no significant change from the control when cells were treated with scrambled shRNA (unpaired t test, P > 0.05). Compared with the control condition, the slope factor (Zδ) was not significantly different with SENP2, SUMO2, shRNA SENP2, and scrambled shRNA (P > 0.05).
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Of note, 1 nM SUMO1 had the same effect on I Ks in CHO cells as 1 nM SUMO2 (Table 2) . To identify potential SUMOylation site(s) in I Ks channels we analyzed the primary sequences of the subunits with an algorithm Human KCNQ1 or KCNQ1-Lys 424 Gln expressed in CHO cells ± KCNE1 and studied as per Fig. 2 with control solution, 1 nM SUMO2, 1 nM SUMO1, or 1 nM SENP2 in the pipette as indicated. V 1/2 and Zδ were determined from a Boltzmann function using tail current densities; tail current density was assessed by estimating the peak from a fit of the decay curve after an activating pulse at +40 mV for 2 s, and the τ for activation and deactivation was determined from a single exponential fit. Data are mean ± SEM for 6-11 cells studied from each condition. Compared with KCNQ1 + KCNE1 (with control pipette solution), V 1/2 , tail current density, τ for activation, and deactivation were significantly different for SENP2-, SUMO2-, and SUMO1-treated conditions and also for KCNQ1-Lys 424 Gln + KCNE1 (with control pipette solution, SENP2, and SUMO2), unpaired t test, *P < 0.05 and **P < 0.01; whereas, the slope factor (Zδ) was not significantly different with SENP2, SUMO2, SUMO1, and KCNQ1-Lys424Gln + KCNE1 (P > 0.05). Compared with KCNQ1 (with control pipette solution), V 1/2 and tail current density were significantly different for SENP2-treated conditions and also for KCNQ1-Lys 424 Gln (with control pipette solution, SENP2, and SUMO2), unpaired t test, ***P < 0.01, but τ for activation and deactivation was not significantly different; V 1/2 , tail current density and τ for activation and deactivation were not significantly different for SUMO2treated conditions (P > 0.05); the slope factor (Zδ) was not significantly different with SENP2, SUMO2, and KCNQ1-Lys424Gln (with control pipette solution, SENP2, and SUMO2), P > 0.05. (31) . We found that mutating Lys 424 to Gln in human KCNQ1 (KCNQ1-Lys 424 Gln), within the motif Phe-Lys-Leu-Asp (similar to the canonical SUMO motif ψ-K-X-E/D), produced a channel that was unresponsive to SUMO2 or SENP2, and that operated like wild-type I Ks treated with SENP2, that is, a channel without linked SUMO2 (Fig. 2) . Thus, I Ks channels formed with KCNE1 and KCNQ1-Lys 424 Gln had a V 1/2 of 7.8 ± 0.8, 7.8 ± 1.6, and 7.6 ± 1.1 mV, when studied under control conditions or with 1 nM SUMO2 or 1 nM SENP2 in the pipette, respectively ( Table 2 ). I Ks produced in CHO cells with mouse KCNQ1 and KCNE1 subunits responded to SUMO2 and SENP2 like their human counterparts and the analogous mutation in mouse KCNQ1 Lys 423 Gln, ablated responsiveness to SUMO2 and SENP2, and yielded a channel that operated like the SENP2-treated wild-type isoform (Fig. S2 ). To examine interactions between I Ks channels and SUMO, we measured FRET in live CHO cells between subunits tagged with CFP and YFP, a strategy we have used to study the SUMOylation of other ion channels (13) (14) (15) (16) . Measured here by the photobleaching rate of the CFP donor, FRET reports on a separation of less than 10 nm between FPs-consistent with a protein-protein interaction ( Fig. 3 A and B) . Tagging wild-type KCNQ1 and KCNQ1-Lys 424 Gln subunits with CFP did not alter their V 1/2 , gating kinetics, or responsiveness to SUMO2 (Fig. S3 ). Similarly, we have previously demonstrated that tagging the N terminus of SUMO with YFP did not alter its operation (13) (14) (15) (16) . FRET was measured between I Ks channels formed with KCNQ1-CFP and YFP-SUMO2. The mean time constant for photobleaching (τ) of 22.5 ± 0.9 s was similar to the value for the interaction of KCNQ1-CFP with the SUMO ligase YFP-Ubc9 (21.6 ± 1.0 s; Fig. 3C ). In contrast, KCNQ1-CFP showed τ of 10.4 ± 1.0 s with both YFP-SUMO2 91 -a variant lacking the terminal GG motif required for covalent linkage-and free YFP (10.5 ± 0.8 s). Similarly, KCNQ1-Lys 424 Gln-CFP did not show FRET with YFP-SUMO2, YFP-SUMO2 91 , free YFP, or YFP-Ubc9, the last meeting expectations because we have previously shown that the SUMO ligase requires its target Lys to bind stably to channel subunits. The lack of FRET between YFP-SUMO2 and I Ks channels formed by KCNQ1-Lys 424 Gln-CFP argues that KCNE1 subunits are not SUMOylated. To determine the stoichiometry of SUMOylation, we counted the number of SUMO2 monomers on individual I Ks channels at the surface of live CHO cells using simultaneous, twocolor TIRF microscopy, and single-particle photobleaching ( Fig. 4 and Table 3 ). We have previously shown that modification of KCNQ1 with TagRFP-T (KCNQ1-RFP) does not alter the expression or the biophysical properties of I Ks channels, and that KCNQ1-RFP can be visualized at the cell surface with other subunits tagged with mTFP1 without confounding spectral overlap (30) . KCNQ1-RFP and mTFP-SUMO2, in the presence of unlabeled KCNE1, were observed together at the cell membrane ( Fig. 4A ). In keeping with the known structure of complete channels, KCNQ1-RFP showed up to four bleaching steps, in a distribution expected (due to prebleaching and missed events) for the uniform expression of tetrameric channel assemblies (Fig. 4A) .
The bleaching analysis of SUMO2 shows up to four steps, consistent with one monoSUMOylation event on each KCNQ1 subunit ( Fig. 4A ).
As in our recent work (30) , we observed no more than two bleaching steps for KCNE1 subunits in individual I Ks channels. Here, with KCNE1-RFP and mTFP-SUMO2 studied in the presence of unlabeled KCNQ1, we observed up to two steps for KCNE1 and up to four steps for SUMO2 ( Fig. 4B ). Based on the statistical strategy of Hines to determine the number of required particles and to estimate accuracy (32), we determine a 2:4 subunit stoichiometry for KCNE1:SUMO in fully SUMOylated single I Ks channels with a confidence approaching 1 ( Table 3 ). Of note, channels formed with KCNQ1-Lys 424 Gln-RFP subunits, and thus no SUMO, also had two mTFP-tagged KCNE1 subunits, indicating that the SUMOylation status of KCNQ1 did not alter the α:β subunit composition of I Ks channels ( Fig. S4 and Table S1 ).
Each SUMO2 in I Ks Channels Has an Additive Effect on Voltage-Dependent Activation. To assess the role of individual SUMO2 adducts, we studied concatemeric I Ks channels that linked together KCNQ1 and/or KCNQ1-Lys 424 Gln subunits (indicated for this experiment here as Q1 and Q1*, respectively) to control the maximum number of SUMO2 that could link to the channel (Fig. 5 ). Thus, KCNE1 was expressed with Q1*-RFP or Q1*-Q1*-RFP (no SUMO sites), Q1*-Q1*-Q1-Q1*-RFP (one site), Q1-Q1*, or Q1*-Q1-RFP (two sites); Q1-Q1-Q1*-Q1-RFP (three SUMO sites); Q1-Q1-RFP or Q1-RFP (four sites). TIRF microscopy (TIRFM) analysis confirmed the enforced stoichiometry of SUMOylation (Tables S2 and  S3 ). Whole-cell recordings showed that each SUMO2 monomer added into the I Ks channels right-shifted the V 1/2 by ∼+8.5 mV. This graded response accounts for the total excursion in the V 1/2 of ∼30 mV (4 × ∼7.5 mV) observed when native I Ks channels in nCM or I Ks channels in CHO cells were studied in conditions expected to fully SUMOylate (1 nM SUMO2 in the pipette) or completely deSUMOylate (1 nM SENP2 in the pipette; Figs. 1 and 2 ). In addition to a change in the voltage required to activate the I Ks channels, SUMOylation also evokes graded changes in gating kinetics, slowing the time course for channel activation by ∼20% and speeding deactivation by ∼20% per SUMO2 added into the complex (Table S4 ). For each concatemer studied, the number of SUMO2 monomers counted was equal to and not greater than the number of Lys 424 residues in the channel complex, arguing against the formation of polySUMO2-chains. Analysis of the surface density of isolated and colocalized fluorescent particles revealed that mTFP-SUMO2 was not observed at the plasma membrane of CHO cells expressing KCNQ1-Lys 424 Gln-RFP subunits with KCNE1, indicating that KCNE1 subunits are not SUMOylated (Table S5) . TIRFM was also used to show that although the current density nearly doubles when I Ks channels are formed with KCNE1 and KCNQ1-Lys 424 Gln subunits compared with wild-type KCNE1 and KCNQ1 subunits, the increase was not associated with a change in the number of channels at the surface of live CHO cells (Table S6) ; thus, SUMOylation did not alter the steady-state surface expression of I Ks channels.
KCNE1 Determines the Valence of SUMOylation. Unexpectedly, KCNQ1 channels, formed in the absence of KCNE1, were found to carry only two SUMO2s (Fig. 6 ). Whole-cell voltage-clamp recording of KCNQ1 channels with 1 nM SENP2 in the pipette showed that deSUMOylation left shifted V 1/2 to −32 ± 1 mV from its control level of −16 ± 1 mV and increased the current-density. With 1 nM SUMO2 in the pipette, the V 1/2 and current density remained unaltered, suggesting that KCNQ1 channels are maximally SUMOylated under control conditions (Fig. 6A ). Channels formed with KCNQ1-Lys 424 Gln showed no change with either SUMO2 or SENP2 in the pipette, with biophysical parameters similar to those observed for KCNQ1 channels studied with 1 nM SENP2 in the recording pipette. Despite this difference from I Ks channels, FRET showed that the Lys 424 site was still mediating interaction with SUMO2 in a fashion that required covalent linkage and allowed assembly with the SUMO ligase, Ubc9 (Fig. 6B) . In contrast to I Ks channels ( Fig. 4 and Fig. 5 ), TIRFM revealed that KCNQ1 channels formed in the absence of KCNE1 were modified at most by two SUMO2 subunits ( Fig. 6C and Table 3 ).
Discussion
In this report, we demonstrate that SUMOylation regulates the biophysical properties of I Ks channels in cardiac myocytes as well as channels formed by heterologous expression of the constituent subunits in CHO cells. I Ks channels can be SUMOylated up to four times and this produces ∼34-mV right-shift in the V 1/2 in nCM and CHO cells; thus, SUMOylation decreases the magnitude of repolarizing current for a given membrane potential, an excitatory effect.
We show that I Ks channels have five distinct SUMOylation states and as the valence of SUMOylation increases from 0 to 4, the V 1/2 of activation is right-shifted by ∼+8 mV per SUMO2, in a stepwise manner. SUMOylation also evokes graded changes in the gating kinetics of I Ks channels, slowing the time course for channel activation by ∼20% and speeding deactivation by ∼20% per SUMO2 added into the complex (Table S4 ). TIRFM shows that the decrease in current density with SUMOylation of I Ks channels is not associated with a change in the number of channels at the surface of live CHO cells (Table S6 ), suggesting that surface turnover of I Ks channels is not SUMO dependent under the conditions of this study. Although the changes in voltage-dependent activation kinetics with SUMOylation are thus sufficient to explain the decrease in current density of I Ks channels, our data do not exclude the possibility that SUMOylation has small effects on the unitary conductance.
Whereas I Ks carries up to four SUMOs, KCNQ1 channels formed without KCNE1 carry a maximum of two SUMOs despite having four Lys 424 binding sites (Fig. 6 ); perhaps this is not surprising because we observed K V 2.1 channels in the absence of accessory subunits are also tetramers that carry a maximum of two SUMO monomers, on nonadjacent subunits (14) . Because I Ks can accommodate up to four SUMO monomers, one per Lys 424 , the incorporation of KCNE1 is surmised to expose either the Ubc9 binding site or the SUMO conjugation site on the two other subunits. Arguing against the proposal that highly SUMOylated KCNQ1 channels are rapidly internalized in the absence of KCNE1, we fail to detect channels with three or four SUMOs at the cell surface in single-molecule photobleaching studies despite the time resolution of our TIRF experiments (1 Hz) and the limited mobility of the channels on the surface of the mammalian cells that we study here at room temperature. It remains possible that if KCNQ1 channels are SUMOylated inside the cell, their transit to the surface might be restricted.
A number of mechanisms might be in play to shift the iG-V relationship of I Ks channels. The shift in the V 1/2 due to KCNE1 in the absence of SUMOylation can be inferred by study of channels formed by KCNQ1-Lys 424 Gln subunits and is estimated to be ∼+38 mV; our study of wild-type I Ks channels shows SUMOylation to produce an excursion of up to ∼+34 mV (Fig. 6D) . Because KCNE1 slows the movement of the voltage sensor domains (VSDs) in KCNQ1 to produce the slow channel activation characteristic of I Ks (8, 33) , SUMOylation might be anticipated to impact the energetics of this conformation change. In addition, the coupling of VSD movement and pore opening is subject to regulation, for example, via PIP2 (34) , and Lys 424 resides between the A and B domains in the intracellular C terminus of KCNQ1, a region associated with regulation of I Ks channel function by calmodulin, phospholipids and kinases (35) .
We observe macroscopic I Ks current in nCM and CHO cells to operate as if the channel population carries an average of two SUMO2 monomers. This finding, and the observation that a decrease in SENP2 mRNA levels decreases I Ks current in nCM, support the conclusion that SUMOylation adjusts the biophysical properties of I Ks channels in the heart. Given that the biophysical properties of native I Ks channels vary subject to neuronal and hormonal influences (1), it is reasonable to posit that natural regulators of I Ks channels may operate via, or in concert with, the SUMO pathway. Further, regulation of the SUMO pathway by acute stressors is now well recognized in the CNS, as shown in our studies of rapid hypoxic regulation of Na V 1.2 in cerebellar granule neurons (15) , and it is therefore reasonable to expect it to act in a similar manner on ion channels in the heart, such as I Ks .
SUMOylation of I Ks decreases the repolarizing current and is thereby expected to prolong the duration of cardiac action potentials in human where it is expressed in adult ventricular myocytes; suppression of I Ks is thus associated with a prolonged QT interval on the surface electrocardiogram. Whereas we study neonatal mice where I Ks is prominent, in animals >6 wk of age the current declines to undetectable levels in ventricular myocytes (10, 27) , which may explain why Qi et al. (17) did not observe a prolonged QT or ventricular arrhythmia with SENP2 knockdown in the adult mice they studied. These authors (17) did observe bradycardia and atrioventricular FP-tagged KCNQ1, SUMO2, and KCNE1 subunits were expressed in CHO cells and studied by TIRFM as described in Fig. 4 . The number of photobleaching steps observed for each fluorophore in each fluorescent spot reports on the stoichiometry of the channel complex. KCNQ1 channels are tetramers and show no more than four bleaching steps when tagged with RFP ( Fig. 4) . Study of KCNQ1 colocalized with mTFP-SUMO2 and untagged KCNE1 reveals a 4:4 stoichiometry of KCNQ1 and SUMO2 in each I Ks channel. The statistical confidence in the null hypotheses that KCNQ1 forms tetramers and that four SUMO2s assemble with each I Ks channel complex was assessed to be greater than 0.98. Prebleaching and variance in quantum efficiency reduce the probability of observing each possible bleaching event (θ). θ is calculated from the value of n and the distribution of the photobleaching data per Hines (32) and as before for I Ks channels (30) . θ is decreased when the distribution is altered to estimate the possibility that higher numbers of missed bleaching steps, for example θ + 1, indicating that this stoichiometry is less likely. (A-V) conduction block in adult mice with SENP2 knockdown that was global or localized to the nervous system but not when it was targeted to the heart; they hypothesize that increased CNS SUMOylation can cause cardiac symptoms of neural origin as well as seizures, and our findings with neonatal cardiac myocytes do not contradict their conclusions. The SUMO pathway has been shown to be active in slow processes in the heart, including cardiac development, regulation of metabolism, and disease progression (36) . Thus, heart-specific constitutive overexpression of SENP2 in mice has been associated with major congenital defects in both the atria and ventricles of the heart (37) . Whereas, chronic viral overexpression of SUMO1 has been reported to have a positive role in treating heart failure, improving cardiomyocyte intracellular calcium homeostasis via effects on SERCA2A calcium pump activity in both a pressure overload heart failure model in mice (38) and an ischemia heart failure model in swine (39) , inducible overexpression of SENP1 in mice is reported to produce mitochondrial dysfunction in ventricular myocytes and attributes resembling heart failure in humans (40) . That two manipulations that increase SUMOylation appear to have opposite effects on the heart is likely to reflect the multiplicity of SUMO pathway targets, stimulus-dependent changes in SUMOylation/deSUMOylation, chronic and acute changes over time, and our nascent understanding of the SUMO pathway.
In addition to the data we present here on I Ks , a growing body of evidence indicates that SUMOylation regulates other cardiac ion channels, including K2P1, K V 2.1, K V 1.5, and TRPM4, that were studied in noncardiac tissues (or heterologous cells) but are natively Fig. 6 . In the absence of KCNE1, KCNQ1 channels carry only up to two SUMOs. KCNQ1 or KCNQ1-Lys 424 Gln channels were expressed in CHO cells without KCNE1 and assessed for whole-cell currents with control, 1 nM SUMO2, or SENP2 in the pipette, as per Fig. 2 ; FRET, as per Fig. 3 ; and stoichiometry by TIRFM (as per Fig. 4 ). Biophysical parameters and single-particle statistical analyses are summarized in Tables 2 and 3 expressed in the heart (12, 14, 16, (41) (42) (43) . Thus, K V 1.5 and K V 2.1 are predominantly expressed in mouse atrial myocytes, where they contribute to the slow-repolarizing current (44) , and K2P1 and TRPM4 are expressed in cardiac Purkinje fibers (45) . A familial missense mutation that increases SUMOylation of TRPM4 has been associated with progressive A-V block (43) . Thus, we expect SUMOylation modulates cardiac physiology in a manner that varies with localization of these SUMO-regulated proteins and activity of SUMO pathway enzymes. As we have found in our studies of central neurons, Xenopus oocytes, COS-7 cells, and CHO cells (12) (13) (14) (15) , SUMO regulation of I Ks in nCM suggests that SUMO pathway enzymes will be found to be resident at the cardiac myocyte plasma membrane and not restricted to the nucleus and cytosol.
Some years ago, we described the family of subunits related to KCNE1, the mink-related peptides (46, 47) , and KCNQ1 has since been shown to assemble with all of them on heterologous expression. As reviewed by Abbott et al. (48) , KCNQ1 has thus far been demonstrated to assemble in vivo with KCNE1 in the heart and inner ear; with KCNE2 in the stomach, thyroid, heart, and choroid plexus; and with KCNE3 in breast, intestine, and airway epithelia. Indeed, KCNQ1 has yet to be shown to operate in the body without a KCNE subunit partner. Given that SUMO2 can modify KCNQ1 subunits in the presence of KCNE1, it is reasonable to assume that SUMO will regulate KCNQ1-containing channels with these other KCNE subunits, because the SUMO pathway is ubiquitous. In contrast, the Chromanol-293B-insensitive portion of the delayed rectifier potassium current in nCM does not appear to be regulated by the SUMO pathway. Although we did not identity its basis, others report that HERG (K V 11.1) passes the Chromanol-293B-insensitive current in nCM (19, 20) .
The stoichiometry of I Ks channels has been an issue of debate for some years. As we have previously observed (30, 49) , I Ks channels studied here in CHO cells form with a fixed stoichiometry of four KCNQ1 subunits and two KCNE1 subunits, a value corroborated by some groups (50, 51) but not others (52) . The data in the current study further supports the conclusion that the subunit composition of I Ks channels does not vary with SUMOylation, and KCNE1 is not SUMOylated (Fig. 4 and Table S5 ).
We focus here on SUMO2 following up on the findings of Qi et al. (17) on M-current channels in the brain. In our hands, SUMO1 in the pipette has the same effects as SUMO2 on I Ks channels in CHO cells. However, it is important to note that although SUMO1 and SUMO2 share some targets, exchanging the native cellular cytosol with pipette buffer containing 1 nM free SUMO or SENP may not faithfully reflect the behavior of the regulators expressed from their genes at low natural levels found in vivo.
Materials and Methods
Molecular Biology and Reagents. Wild-type human KCNQ1 (NCBI ACC no. NM_000218), human KCNE1 (NP_000210.2), mouse KCNQ1 (NCBI ACC no. NM_008434), and mouse KCNE1 (NCBI ACC no. NM_008424) were handled in pRAT, an in-house vector as previously described (8, 30) . Human SUMO2 95 and Ubc9 were amplified from a brain cDNA library (Clontech) and inserted into pMAX. Point mutations were introduced by QuikChange mutagenesis (Agilent). TagRFP-T (RFP), mTFP1 (TFP), YFP, and CFP genes were inserted in-frame with the KCNQ1, KCNE1, SUMO2, or Ubc9 where noted, as before (15, 30) . SUMO2 and SENP2 were purchased from Boston Biochem. Isradipine and Chromanol-293B were purchased from Sigma-Aldrich.
Neonatal Mouse Ventricular Myocyte Primary Culture. Neonatal ventricular myocytes were cultured from mice. Briefly, postnatal day 1-3 CD-1 mouse pups (Charles River) were decapitated and the ventricles were dissected, cut into 1-mm squares, and incubated with 0.15% Collagenase Type I (Worthington) in calcium-free, magnesium-free HBSS for 1 h at 37°C. The tissue was triturated with a fire-polished Pasteur pipette, passed through a cell strainer (35 μm) to remove extraneous debris, and plated onto 25-mm diameter glass coverslips precoated with gelatin (0.1% in sterile water; ATCC). The cells are maintained in DMEM (Thermo Fisher) supplemented with 10% horse serum (ATCC) and 5% FBS (ATCC) and 1% penicillin and streptomycin (Thermo Fisher) at 5% CO 2 and 37°C for 72 h before experiments. Spontaneous beating and muscular striations were used to identify cells in culture as myocytes.
SENP2 Lentiviral Particle Knock-Down Assay and qPCR Analysis. Lentiviral particles expressing GFP and an shRNA targeting mouse SENP2 or a scrambled control (OriGene Technologies) were applied to nCM for 12 h, where indicated. Cells were studied for 48 h following infection and were identified visually by the expression of GFP. Fluorescent cells (5-10 cells) were collected by glass electrodes and analyzed with the Single-Cell-to-CT Kit (Thermo Fisher Scientific) according to the manufacturer's guidelines. In brief, the cells were lysed at room temperature and reverse transcription was performed in a thermal cycler. The products from reverse transcription were used for the real-time RT-PCR on a Rotor-Gene Q cycler (QIAGEN) according to the manufacturer's instructions. TaqMan Gene Expression Assays were acquired from Thermo Fisher Scientific for both SENP2 and GAPDH. All reactions were done in triplicates.
Cell Culture and Heterologous Expression. CHO-K1 cells (RRID: CVCL_0214) were purchased from ATCC, identity authenticated by cytochrome c oxidase I analysis, demonstrated to be mycoplasma free by Hoechst DNA stain and agar by culture, and maintained in F12K medium supplemented with 10% FBS (ATCC). Plasmids were transfected into cells with Lipofectamine 2000 according to the manufacturer's instructions (Thermo Fisher). CHO cells for patch-clamp studies were cotransfected with eGFP for experiments performed without FP-tagged channel subunits. Experiments were performed 36-48 h posttransfection at room temperature.
Whole-Cell Voltage-Clamp Electrophysiology. Whole-cell potassium currents were recorded with an Axopatch 200B amplifier and pCLAMP software (Molecular Devices) at filter and sampling rates of 2 and 10 kHz, respectively. CHO cells were bathed in a solution comprising, in mM: 130 NaCl, 4 KCl, 1.2 MgCl 2 , 2 CaCl 2 , and 10 Hepes; pH was adjusted to 7.4 with NaOH. Recording electrodes were fabricated from borosilicate glass (Warner) and fire polished to have a resistances of 2-4 MΩ when filled with a solution containing, in mM: 130 KCl, 1 MgCl 2 , 5 EGTA, 5 K 2 ATP, and 10 Hepes; pH was adjusted to 7.4 with KOH. CHO cells had a mean whole-cell capacitance of 14 ± 0.6 pF; series resistance was typically <5 MΩ, and the voltage error of <3 mV was not adjusted for. Cells for study were selected based on fluorescence color (free eGFP in the absence of FP-tagged subunits). Currents were evoked from CHO cells with 2-s test pulses from −120 to 80 mV from a holding potential of −80 mV, with 20-mV increments. Tail currents were recorded at −40 mV for 2 s. The interpulse interval was 15 s. Neonatal cardiac myocytes were studied in a bath solution comprising, in mM: 132 NaCl, 4.8 KCl, 2 CaCl 2 , 1.2 MgCl 2 , 10 Hepes, 5 glucose, pH 7.4, with 1 μM isradipine to block voltage-gated calcium channel currents. Pipettes were filled with a solution containing, in mM: 125 K-aspartate, 20 KCl, 10 EGTA, 10 ATP(Mg), and 10 Hepes, pH 7.3. nCM had a mean whole-cell capacitance of 30 ± 3.57 pF; series resistance was typically <5 MΩ, the voltage error of <2.5 mV was not adjusted for. Currents were evoked from nCM with 2-s test pulses from -60 to 60 mV from a holding potential of -40 mV, with 20-mV increments. Tail currents were recorded at −40 mV for 2 s. I Ks was isolated by subtraction of the current measured in the presence of 30 μM Chromanol-293B, a I Ks inhibitor, from the current measured before application of the drug. I Ks -like currents were observed in ∼70% of nCM. Conductance (G) was calculated from the tail currents and expressed as G/Gmax as a function of the membrane voltage. G-V curves were obtained and fit to the equation G = Gmax − 1=½1 + expððV − V1=2Þ=zδÞ as previously described (8, 30) , where V is the test potential, V 1/2 is the voltage of half-maximal activation, and zδ is the slope factor. Activation and deactivation kinetics were analyzed by fitting the current traces with a single-exponential equation and are reported as τ act and τ deact , respectively. Current density was measured from fits of tail current decay after an activating pulse of +40 mV lasting 2 s. All of the experiments were performed at room temperature and all electrophysiological data were analyzed in pCLAMP (Molecular Devices), Excel, and OriginLab software.
Live-Cell FRET Experiments and Analysis. FRET technique was used with live CHO cells to evaluate and validate the direct protein-protein interaction between the SUMO protein and the KCNQ1 channel, which were heterologously expressed at the cell surface. YFP-tagged SUMO2 and CFP-tagged KCNQ1 or KCNQ1-Lys 424 Gln was transfected, with KCNE1 where indicated. The FRET imaging data were collected using a fluorescence microscope (IX81; Olympus). CFP and YFP were excited at 458 and 514 nm, respectively, and the emission light was collected by bandpass filter of 470-500 nm and 525-575 nm, respectively (14) . Images were captured using a CCD camera controlled by MetaMorph software (Molecular Devices) and analyzed with ImageJ.
TIRFM and Single-Particle Photobleaching. Single-protein particle complexes at the surface of live CHO cells were identified and studied by TIRFM as previously Xiong et al.
PNAS | Published online July 25, 2017 | E6693 PHYSIOLOGY PNAS PLUS described (15, 30) . Briefly, the critical angle for TIRF was adjusted using a CellTIRF illuminator (Olympus) and a high numerical-aperture Apochromat objective (150×, 1.45 N.A.; Olympus) mounted on an automated fluorescence microscope (IX81; Olympus), controlled by MetaMorph software (Molecular Devices). For simultaneous illumination of two fluorophores, CellTIRF software (Olympus) was used to adjust the critical angle for each excitation wavelength to generate evanescent waves of equivalent depth (100 nm). A 561-nm laser line was used to excite RFP, and a 445-nm laser line to excite mTFP. When mTFP was studied with RFP simultaneously, emitted light signals were split by using a 520-nm dichroic mirror mounted in a Dual View adapter (Photometrics), and each wavelength was directed to one-half of a back-illuminated EM-CCD (Hamamatsu).
Analysis of Fluorescence Colocalization and Subunit Stoichiometry. Fluorophores were photobleached by continual excitation, and data were captured as movies of 100-400 frames acquired at 1 Hz. When TFP was studied with RFP in the same cell, the data for each fluorophore were saved as separate stacks and processed in an identical manner. Misalignment of the data between stacks was corrected in ImageJ using the StackReg plugin. Next, the degree of colocalization between two fluorophores was determined by unbiased intensity correlation analysis using the Coloc2 plugin to obtain the Manders' coefficient for each cell. For stoichiometric analysis, fluorescent spots were defined as a discrete 3 × 3 pixel region around a pixel of maximum intensity, as before (15, 30) . Fluorescence is reported as the change in fluorescence normalized by the initial level of fluorescence for each trace. Statistical analyses to assess the estimated confidence with which stoichiometry can be inferred from the observed data and θ, the probability of successfully observing each possible photobleaching event were performed in RStudio as described (15, 30) . The densities of colocalized and single fluorescent spots were determined following thresholding and watershed separation in ImageJ. Then, the particle number was counted in four, separate 30 × 30 pixel regions of interest for five cells per group using the Analyze plug-in.
Statistical Analysis. Statistical analyses (unpaired t tests) were performed on biophysical parameters, cell surface density of fluorescent particles, and FRET photobleaching time-constants data using pCLAMP (Molecular Devices), Excel and OriginLab software and the statistical significance is indicated in table and figure legends. The statistical significance of TIRF photobleaching parameters was analyzed in RStudio, as before (15) .
